Finance

Lists
Q3 2026 earnings • released • EPS miss -५३.७७% • Revenue beat +०.५०%
See results
FME:ETR
Fresenius Medical Care AG
€ ४२.२३
-०.२१%
(-०.०९०) 1D
नोभेम्बर ६, १७:३६:२८ GMT+१  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for FME...
Open
€ ४२.५९
High
€ ४२.६०
Low
€ ४१.५०
Mkt. cap
११.३६ अरब
Avg. vol.
९.८८ लाख
Volume
१२.६४ लाख
Dividend
३.५३%
Quarterly dividend
€ ०.३७
Ex-dividend date
२०२६ मे २२
P/E ratio
१४.११
52-wk high
€ ४५.९०
52-wk low
€ ३४.५७
EPS
€ २.९९
Shares outstanding
२६.८६ करोड
No. of employees
१ लाख
Open
€ ४२.५९
High
€ ४२.६०
Low
€ ४१.५०
Mkt. cap
११.३६ अरब
Avg. vol.
९.८८ लाख
Volume
१२.६४ लाख
Dividend
३.५३%
Quarterly dividend
€ ०.३७
Ex-dividend date
२०२६ मे २२
P/E ratio
१४.११
52-wk high
€ ४५.९०
52-wk low
€ ३४.५७
EPS
€ २.९९
Shares outstanding
२६.८६ करोड
No. of employees
१ लाख
News stories
From web sources and news partners
VZ VermögensZentrum
VZ VermögensZentrum
·
१६ घण्टा पहिले
Fresenius Medical Care sees 2026 operating income flat to down mid-single digits
GuruFocus
GuruFocus
·
१७ घण्टा पहिले
Fresenius Medical Care AG (FMS) (Q3 2026) Earnings Call Highligh
Yahoo Finance
Yahoo Finance
·
२ दिन पहिले
Fresenius Medical Care AG (FMS) Stock Forecasts
Profile
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives. With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan. The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue. As of 2024, the company was ranked as #612 on the World's Best Employers list published by Forbes. Wikipedia
About Fresenius Medical Care AG
CEOHelen Giza
Employees१.०६ लाख
Founded१९९६
Headquarters-
SectorHealth Care
Industry-
Last report
२०२६ नोभेम्बर ३
Fiscal period
Q3 2026
€ ०.५६ / € १.२०
-५३.७७%miss
Revenue / Est. (EUR)
४.९४ अरब / ४.९१ अरब
+०.५०%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
५.०७ अरब
४.६१ अरब
४.८६ अरब
४.९४ अरब
Cost of goods sold
३.६८ अरब
३.४३ अरब
३.५५ अरब
३.६६ अरब
Cost of revenue
३.६८ अरब
३.४३ अरब
३.५५ अरब
३.६६ अरब
Research and development expenses
३.८६ करोड
३.८३ करोड
३.९६ करोड
४.१४ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
७८.४६ करोड
७४.८९ करोड
७३.६० करोड
७४.३६ करोड
Operating expense
७९.६३ करोड
८०.३९ करोड
७८.६४ करोड
७९.९९ करोड
Total operating expenses
४.४८ अरब
४.२४ अरब
४.३४ अरब
४.४६ अरब
Operating income
५९.२० करोड
३७.५६ करोड
५२.३६ करोड
४७.५५ करोड
Other non operating income
-
-
-
-
EBT including unusual items
५०.८५ करोड
२०.७५ करोड
३८.३० करोड
३०.२६ करोड
EBT excluding unusual items
५४.१८ करोड
३३.४४ करोड
३९.९२ करोड
४०.५४ करोड
Income tax expense
१०.६४ करोड
४.२८ करोड
८.९८ करोड
७.७८ करोड
Effective tax rate
२०.९३%
२०.६०%
२३.४५%
२५.७२%
Other operating expenses
-२.६९ करोड
१.६७ करोड
१.०७ करोड
१.४९ करोड
Net income
३२.७१ करोड
११.७५ करोड
२१.८४ करोड
१५.९८ करोड
Net profit margin
६.४५%
२.५५%
४.४९%
३.२४%
Earnings per share
१.४४
०.९१
०.५६
०.५६
Interest and investment income
१.३६ करोड
१.४६ करोड
१.४७ करोड
१.६० करोड
Interest expense
-९.९० करोड
-९.३३ करोड
-९.७६ करोड
-९.७५ करोड
Net interest expenses
-८.५४ करोड
-७.८७ करोड
-८.२९ करोड
-८.१५ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
७८.०२ करोड
७२.७८ करोड
८७.९४ करोड
८२.९८ करोड
Gain or loss from assets sale
१.७९ करोड
८७.७१ लाख
-४०.९४ लाख
-७१.८२ लाख
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू